Hadasit Bio Holdings (HBL)

A publicly traded Israeli VC fund focused on biotechnology and medical, commercializing IP from Hadassah University Hospital.

Venture Capital Jerusalem, Israel Est. 2005
Visit website ↗
Last updated 2026-10-28
Portfolio
1
in our dataset
Rounds participated
1
Rounds led
1
Rounds' value
$8.0M
total disclosed, rounds participated
Stages
Seed, Series A, Series B, Venture - Series Unknown, Funding Round

About

Hadasit Bio-Holdings Ltd. (HBL) is a publicly traded subsidiary of Hadasit Ltd., the technology transfer company of the Hadassah University Hospital in Jerusalem, Israel. HBL was established to allow public investment in biotechnology companies based on intellectual property generated by Hadassah University Hospital. It focuses on funding portfolio companies through Phase I and preparation for Phase II clinical trials, primarily in biomedicine.

Portfolio · 1

Enlivex
A clinical-stage macrophage reprogramming immunotherapy company developing Allocetra™ for inflammatory diseases and operating a prediction markets treasury.
Led ★ 1 round $8.0M committed Latest: 2017-09

Q&A

What is Hadasit Bio Holdings (HBL)'s primary investment focus?
Hadasit Bio Holdings (HBL) is a publicly traded Israeli VC fund that focuses on biotechnology and medical companies, specifically those commercializing intellectual property from Hadassah University Hospital.
What is the typical investment stage for Hadasit Bio Holdings (HBL)?
Hadasit Bio Holdings (HBL) invests across various stages including Seed, Series A, Series B, Venture - Series Unknown, and general Funding Rounds.
What sectors does Hadasit Bio Holdings (HBL) prefer for investments?
Hadasit Bio Holdings (HBL) prefers investments in Biotechnology, Medical, Health Tech & Life Sciences, Pharmaceutical, and Biopharma sectors.
Where is Hadasit Bio Holdings (HBL) headquartered?
Hadasit Bio Holdings (HBL) is headquartered in Jerusalem, Israel.
What is Hadasit Bio Holdings (HBL)'s investment thesis?
HBL invests in early-stage Israeli biotech companies, mainly originating from Hadassah University Hospital, with programs in immuno-oncology, ophthalmology, and inflammatory diseases.
What is the typical check size for Hadasit Bio Holdings (HBL)?
Hadasit Bio Holdings (HBL)'s typical check size ranges from $10,000,000 to $47,000,000 USD.
When was Hadasit Bio Holdings (HBL) founded?
Hadasit Bio Holdings (HBL) was founded in September 2005.
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)

External links

Websitehbl.co.il

Identifiers & details

Legal nameHadasit Bio-Holdings Ltd.
Founded2005-9